Prosecution Insights
Last updated: July 17, 2026

Examiner: CLAYTOR, DEIRDRE RENEE

Tech Center 1600 • Art Units: 1617 1627 1651 1691

This examiner grants 43% of resolved cases

Performance Statistics

42.8%
Allow Rate
-17.2% vs TC avg
505
Total Applications
+26.9%
Interview Lift
1434
Avg Prosecution Days
Based on 498 resolved cases, 2023–2026

Rejection Statute Breakdown

1.2%
§101 Eligibility
4.3%
§102 Novelty
61.1%
§103 Obviousness
6.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18290377 Emulsion or Oil-Dispersion Cosmetic Composition Containing High Content of Powder Non-Final OA LG Household & Health Care Ltd.
18511496 SHP2-Targeting Small Molecules For Use As Anti-Cancer Agents Non-Final OA West Virginia University Board of Governors on behalf of West Virginia University
18291016 Methods for Inhibiting the Progression of Oxidative Retinal Disease Non-Final OA BioJiva LLC
18374663 A SYNTHESIS OF POTASSIUM 5,7-DINITRO-[2,1,3]-BENZOXADIAZOL-4-OLATE-3-OXIDE Non-Final OA PRIMODIA CHEMICALS AND PHARMACEUTICALS PRIVATE LIMITED
18475687 Analgesic Therapeutics Based on conjugation of Biocompatible Polymers to Ion Channel Modulators Non-Final OA Relevium Medical

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month